Browse by Journal Title

2022

The role of CD4 T cells in rejection of solid tumors.
Poncette, L., Bluhm, J. and Blankenstein, T.
Current Opinion in Immunology 74 : 18-24. February 2022

2015

Targeting cancer-specific mutations by T cell receptor gene therapy.
Blankenstein, T., Leisegang, M., Uckert, W. and Schreiber, H.
Current Opinion in Immunology 33 : 112-119. April 2015

2005

The role of tumor stroma in the interaction between tumor and immune system.
Blankenstein, T.
Current Opinion in Immunology 17 (2): 180-186. 1 January 2005

2003

The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.
Blankenstein, T. and Qin, Z.H.
Current Opinion in Immunology 15 (2): 148-154. April 2003

Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development.
Mueller, G. and Lipp, M.
Current Opinion in Immunology 15 (2): 217-224. April 2003

2000

NF-kappaB and the innate immune response.
Hatada, E.N., Krappmann, D. and Scheidereit, C.
Current Opinion in Immunology 12 : 52-58. 1 February 2000

1997

Advances in gene targeting methods.
Kühn, R. and Schwenk, F.
Current Opinion in Immunology 9 (2): 183-188. April 1997

1994

Regulation of Apoptosis in the Immune System.
Krammer, P.H., Behrmann, I., Daniel, P.T., Dhein, J. and Debatin, K.M.
Current Opinion in Immunology 6 (2): 279-289. 1 April 1994

Origin, structure and motifs of naturally processed MHC class II ligands.
Roetzschke, O. and Falk, K.
Current Opinion in Immunology 6 (1): 45-51. February 1994

1993

MHC molecules as peptide receptors.
Rammensee, H.G., Falk, K. and Roetzschke, O.
Current Opinion in Immunology 5 (1): 35-44. 1 February 1993